C
CollPlant Biotechnologies Ltd D
D
CLGN
0.40360
USD
-0.02
(-4.13%)
Market Closed
Volume
400
EPS
-2
Div Yield
-
P/E
-0
Market Cap
5,817,946
Title: CollPlant Biotechnologies Ltd
Sector: Healthcare
Industry: Biotechnology
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.